{"id": "179693", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/certainty-of-evidence", "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-assessment"], "versionId": "13", "lastUpdated": "2025-10-21T10:28:59.837Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Low certainty evidence (GRADE)</p></div>", "status": "additional"}, "title": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "citeAs": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-10-21. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json.", "content": [{"type": {"coding": [{"code": "rating-system", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Rating System"}]}, "classifier": [{"coding": [{"code": "GRADE", "system": "http://hl7.org/fhir/uv/ebm/CodeSystem/evidence-rating-system-classifier-codesystem", "display": "GRADE"}]}], "freeToShare": true}, {"type": {"coding": [{"code": "Overall", "system": "http://terminology.hl7.org/CodeSystem/certainty-type", "display": "Overall certainty"}]}, "classifier": [{"coding": [{"code": "low", "system": "http://terminology.hl7.org/CodeSystem/certainty-rating", "display": "Low quality"}]}], "freeToShare": true}], "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-description", "valueMarkdown": "This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence."}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "179693", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "ArtifactAssessment", "artifactReference": {"type": "Evidence", "display": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "reference": "Evidence/55"}}